Join to View Full Profile
3400 Spruce St1 MaloneyPhiladelphia, PA 19104
Phone+1 215-662-3681
Dr. Ahmadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2011
Boston University Medical CenterResidency, Internal Medicine, 2005 - 2007
Medizinische Fakultät Universität zu KölnClass of 2001
Certifications & Licensure
PA State Medical License 2008 - 2012
Publications & Presentations
PubMed
- Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects.Michela Capello, Angelica Sette, Theo Plantinga, Craig J Thalhauser, Vanessa M Spires
Journal for Immunotherapy of Cancer. 2025-04-10 - 3 citationsDaratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.Meletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, Yael C Cohen, Vania Hungria
The New England Journal of Medicine. 2024-12-09 - 18 citationsEpcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.Kim M Linton, Umberto Vitolo, Wojciech Jurczak, Pieternella J Lugtenburg, Emmanuel Gyan
The Lancet. Haematology. 2024-08-01
Press Mentions
- Bispecific Antibodies Poised to Deliver Wave of Cancer TherapiesMarch 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
